A detailed program will be available in early 2019. Abstract submissions and sponsorship/exhibitor applications will be available mid-October.
Proteros is a biotech company focused on enabling lead discovery for challenging targets based on its unique expertise and understanding of protein and small molecule interactions. Co-founded in 1999 by Nobel Laureate Professor Robert Huber, the company has established a global service business that includes 18 of the 20 largest pharmaceutical companies.
Director, Structural Biology
Genomics Institute of the Novartis Research Foundation (GNF)